People · Operator
Named in public records as an officer, director or promoter · active 2008–2023 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| DarioHealth Corp. | — | Biotechnology | Series C | $286.5M | $97.7M | 2014 |
| Cagent Vascular, Inc. | — | Other Health Care | Series B | $48.5M | $213.4M | 2021 |
| Noninvasive Medical Technologies Inc | — | Other Health Care | Series A | $6.3M | $126.3M | 2008 |
| Photomedex Inc | — | Other Health Care | Seed | $4.3M | $35.0M | 2014 |
Dennis McGrath at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dennis McGrath on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Dennis M McGrath | 2 | 5 |
| Richard Anderson | 1 | 10 |
| Peter Schneider | 1 | 8 |
| Brian Walsh | 1 | 7 |
| Marc-Andre Marcotte | 1 | 6 |
| Richard Stone | 1 | 6 |
| Lewis C. Pell | 1 | 5 |
| Steven Nelson | 1 | 5 |
| Gadi Levin | 1 | 5 |
| David W Anderson | 1 | 5 |
| Malcolm Hoenlein | 1 | 4 |
| Adam K Stern | 1 | 4 |
| Peter Kash | 1 | 4 |
| Adam Stern | 1 | 4 |
| Steven Kaplan | 1 | 3 |
| Peter A. Schneider | 1 | 3 |
| TED SPOLTORE | 1 | 3 |
| Adam D. Stern | 1 | 3 |
| Carol A. Burns | 1 | 3 |
| Chen Franco-Yehuda | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.